MENU
GNMSF
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
Genmab A/S (GNMSF) Ownership - Who owns Genmab A/S?
Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer... Show more
Profile
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
13.59B
P/E Ratio
12.70
Total Cash
3.23B
Projected Growth
1.14
Total Debt
143M
Revenue
3.12B
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash/Share
52.45
Total Debt/Equity
N/A
Revenue/Share
48.46 USD as % of share price
Fundamentals
GNMSF
Capitalization
13.6B
P/E Ratio
12.70
Risk (Beta)
0.98
Dividend Yield
N/A
Total Cash
3.23B
Total Cash/Share
52.45
Total Debt
143M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
1.14
Revenue/Share (as % of the share price)
48.46%
Revenue
3.12B
ROE
N/A
Book Value
5.3B
P/B Ratio
2.51
Cash Flow
N/A
Earnings
17.15
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
10M
Current Ratio
5.34
Current Revenue Per Employee
271038.66
Dividends Per Share - Security
N/A
EBITDA
1.35B
Float
N/A
Float - Current
N/A
Gross Income Margin
94.13
Revenue To Assets
18.46
Shares Held By Institutions
18.8B
Shares Outstanding - Current
61.5M
Total Liabilities
1.29B
Total Volume MTD
N/A
Value
N/A
Gain YTD
4.349
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
Carl Jacobsens Vej 30
Phone
+45 70202728
Employees
2204
Web
https://www.genmab.com